Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record no longer includes a MedlinePlus Genetics link associated with schizophrenia-related information.
    Difference
    0.1%
    Check dated 2026-11-14T13:42:20.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record page changed from displaying a 403 Forbidden error to a “TypeError: Failed to fetch” message, and the NIH transition notice disappeared.
    Difference
    1%
    Check dated 2026-11-07T13:20:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T14:09:09.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and notes that “Super Intelligence” is replacing “Artificial Intelligence” in some federal agency content.
    Difference
    1%
    Check dated 2026-10-24T15:44:42.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:35:46.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T15:35:29.000Z thumbnail image

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.